Adial Pharmaceuticals ADIL
NASDAQ ADIL
$4.11 -0.11 (-2.61%)
As of: Oct 23, 2026 · 12:34 PM EDT

Adial Pharmaceuticals (ADIL) Net Debt Issuances and Repayments (2017 - 2018)

Updated

Analysis

Adial Pharmaceuticals (ADIL) Net Debt Issuances and Repayments (2017 - 2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Debt Issuance (Qtr)
1 Eli Lilly 1,133.17 Bn 1,101.76 Bn 19.71 Bn 11.58 Bn
2 Johnson & Johnson 634.79 Bn 554.65 Bn 17.30 Bn -4.36 Bn
3 AbbVie 506.40 Bn 479.51 Bn 12.70 Bn -2.00 Bn
4 Merck 357.93 Bn 312.31 Bn 12.21 Bn -5.00 Mn
5 Novartis Ag 292.69 Bn 256.68 Bn 11.24 Bn 2.17 Bn
6 Astrazeneca 265.19 Bn 238.87 Bn 12.86 Bn -2.46 Bn
7 Amgen 238.22 Bn 193.61 Bn 7.24 Bn -
8 Gilead Sciences 195.23 Bn 169.43 Bn 6.22 Bn -17.00 Mn
9 Pfizer 171.11 Bn 117.76 Bn 10.94 Bn 64.00 Mn
10 Adial Pharmaceuticals 19.00 Mn -24.79 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 -510,000.00
Jun 30, 2018 284,999.00
Mar 31, 2018 250,001.00
Dec 31, 2017 -150,000.00
API Access

Adial Pharmaceuticals Net Debt Issuances and Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-debt-issuances-and-repayments&ticker=ADIL&period=max&api_key=YOUR_API_KEY